- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05656365
Utvärdering av genetik och immunologi för periodisk feber, aftös stomatit, faryngit och cervikal adenit (PFAPA) syndrom och andra tonsillstörningar
Background:
Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) is the most common periodic fever syndrome of childhood. Symptoms can include swelling of the glands in the throat, mouth ulcers, and tonsillitis. Removal of the tonsils can stop the periodic flareups. But researchers do not know how PFAPA develops. In this natural history study, researchers will collect specimens and data from people with PFAPA to see what they might have in common.
Objective:
To collect blood and other specimens from people with PFAPA to learn more about the illness.
Eligibility:
People aged 1 month or older with symptoms of PFAPA or another tonsil disorder.
Design:
Participants will be screened. Their medical records will be reviewed. Researchers will ask about a family history of PFAPA.
The following specimens may be collected:
Blood. Blood will be drawn either from a needle inserted into a vein or from a prick in the finger or heel.
Mucus and cells. A stick with soft padding on the tip may be rubbed inside the nostrils or mouth.
Stool.
Saliva.
Tissue samples may be taken if participants are having surgery to remove the tonsils or adenoids. Participants having surgery may also have a nasopharyngeal wash; salt water will be squirted into the back of the throat and then sucked back out with a syringe.
Most participants will provide specimens only once. They can do this in person at the clinic; they can also have their local health providers send specimens to the researchers. Some participants may have optional follow-up visits over 10 years.
Studieöversikt
Status
Detaljerad beskrivning
Study Description:
The purpose of this multisite study is to collect specimens and data from patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome and other tonsil disorders for genetic, immunologic, cellular, molecular, and microbial research into the pathogenesis of these conditions. Specimens include blood, saliva, buccal swabs, oropharyngeal swabs, nasopharyngeal swabs, nasopharyngeal wash, and/or stool. If a participant is scheduled to undergo a clinically indicated tonsillectomy and/or adenoidectomy, then leftover clinical specimens will also be collected for research. Participants may either be seen in person at the study sites or may be seen remotely via telehealth and provide send-in samples collected locally.
Primary Objective:
To collect samples to understand the immunologic mechanisms and genetic and microbial risk factors for PFAPA and other tonsil disorders.
Primary Endpoints:
- Identify genetic risk variants for PFAPA and other tonsil disorders.
- Characterize immune cell populations, gene expression (including at the single-cell level), epigenetic features, and protein expression ex vivo in blood, tissue, washes, or swabs from people with PFAPA and other tonsil disorders.
- Characterize the tonsillar/adenoid, oral, nasal and/or stool microbiota in people with PFAPA and other tonsil disorders.
- Characterize clinical outcomes following tonsillectomy and other clinically indicated treatments.
Secondary Objective: To understand the characteristics and function of unique cell populations in the pharyngeal lymphoid tissues (tonsils and adenoids) and how immune responses to antigens are generated in these tissues.
Secondary Endpoints:
- Study responses to antigens and infection in the mucosal lymphoid tissue and peripheral blood.
- Characterize unique immune cell populations present in the mucosal tissue.
- Characterize immunologic and molecular pathways in the tissue cells.
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Mary T Bowes
- Telefonnummer: (240) 408-0970
- E-post: mbowes@cc.nih.gov
Studera Kontakt Backup
- Namn: Kalpana Manthiram, M.D.
- Telefonnummer: (301) 529-4787
- E-post: kalpana.manthiram@nih.gov
Studieorter
-
-
District of Columbia
-
Washington D.C., District of Columbia, Förenta staterna, 20010
- Har inte rekryterat ännu
- Children's National Medical Center
-
Kontakt:
- Srinivasalu Hemalatha
- Telefonnummer: 202-476-2800
- E-post: HSriniva@childrensnational.org
-
-
Indiana
-
Indianapolis, Indiana, Förenta staterna, 46290
- Rekrytering
- Indiana University School of Medicine
-
Kontakt:
- Rachel Lemont
- Telefonnummer: 317-944-7260
- E-post: rlemont@iu.edu
-
Kontakt:
- Annette Childress
- Telefonnummer: (317) 944-7260
- E-post: afoti@iu.edu
-
-
Maryland
-
Bethesda, Maryland, Förenta staterna, 20892
- Rekrytering
- National Institutes of Health Clinical Center
-
Kontakt:
- For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)
- Telefonnummer: TTY dial 711 800-411-1222
- E-post: ccopr@nih.gov
-
Kontakt:
- Mary Bowes
- Telefonnummer: (240) 408-0970
- E-post: mbowes@cc.nih.gov
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Patients diagnosed with PFAPA and other tonsil disorders.
Beskrivning
- INCLUSION CRITERIA:
Participants must meet all the following inclusion criteria to be eligible for this study:
- Aged >=1 month. To be seen at the NIH CC, participants must be >=3 years of age.
- Diagnosed with PFAPA or another tonsil disorder, or has symptoms consistent with these conditions, as determined by the investigator.
- Able to provide informed consent (for ages >=18 years) or has a parent or guardian who can provide informed consent on their behalf (for ages <18 years).
- Willing to allow specimens and data to be stored for future research.
- Willing to allow genetic testing on their biospecimens.
EXCLUSION CRITERIA:
An individual who has any condition that, in the judgment of the investigator, may put them at undue risk or make them unsuitable for participation in the study will be excluded.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
|---|
|
Patients
Patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome and other tonsil disorders. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Identify genetic risk variants for PFAPA and other tonsil disorders
Tidsram: Throughout study
|
To collect samples to understand the immunologic mechanisms and genetic and microbial risk factors for PFAPA and other tonsil disorders |
Throughout study
|
|
Characterize clinical outcomes following tonsillectomy and other clinically indicated treatments.
Tidsram: Throughout study
|
To collect samples to understand the immunologic mechanisms and genetic and microbial risk factors for PFAPA and other tonsil disorders |
Throughout study
|
|
Characterize the tonsillar/adenoid, oral, nasal and/or stool microbiota in people with PFAPA and other tonsil disorders
Tidsram: Throughout study
|
To collect samples to understand the immunologic mechanisms and genetic and microbial risk factors for PFAPA and other tonsil disorders |
Throughout study
|
|
Characterize immune cell populations, gene expression including at the single cell level, epigenetic features, and protein expression ex vivo in blood, tissue, washes, or swabs from people with PFAPA and other tonsil disorders
Tidsram: Throughout study
|
To collect samples to understand the immunologic mechanisms and genetic and microbial risk factors for PFAPA and other tonsil disorders |
Throughout study
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Characterize immunologic and molecular pathways in the tissue cells.
Tidsram: Throughout study
|
To understand the characteristics and function of unique cell populations in the pharyngeal lymphoid tissues (tonsils and adenoids) and how immune responses to antigens are generated in these tissues |
Throughout study
|
|
Study responses to antigens and infection in the mucosal lymphoid tissue and peripheral blood.
Tidsram: Throughout study
|
To understand the characteristics and function of unique cell populations in the pharyngeal lymphoid tissues(tonsils and adenoids) and how immune responses to antigens are generated in these tissues |
Throughout study
|
|
Characterize unique cell populations and the immunologic and molecular pathways in the tissue cells
Tidsram: Throughout study
|
To understand the characteristics and function of unique cell populations in the pharyngeal lymphoid tissues (tonsils and adenoids) and how immune responses to antigens are generated in these tissues |
Throughout study
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Kalpana Manthiram, M.D., National Institute of Allergy and Infectious Diseases (NIAID)
Publikationer och användbara länkar
Allmänna publikationer
- Stojanov S, Lapidus S, Chitkara P, Feder H, Salazar JC, Fleisher TA, Brown MR, Edwards KM, Ward MM, Colbert RA, Sun HW, Wood GM, Barham BK, Jones A, Aksentijevich I, Goldbach-Mansky R, Athreya B, Barron KS, Kastner DL. Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade. Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7148-53. doi: 10.1073/pnas.1103681108. Epub 2011 Apr 8.
- Manthiram K, Preite S, Dedeoglu F, Demir S, Ozen S, Edwards KM, Lapidus S, Katz AE; Genomic Ascertainment Cohort; Feder HM Jr, Lawton M, Licameli GR, Wright PF, Le J, Barron KS, Ombrello AK, Barham B, Romeo T, Jones A, Srinivasalu H, Mudd PA, DeBiasi RL, Gul A, Marshall GS, Jones OY, Chandrasekharappa SC, Stepanovskiy Y, Ferguson PJ, Schwartzberg PL, Remmers EF, Kastner DL. Common genetic susceptibility loci link PFAPA syndrome, Behcet's disease, and recurrent aphthous stomatitis. Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14405-14411. doi: 10.1073/pnas.2002051117. Epub 2020 Jun 9.
- Xu Q, Milanez-Almeida P, Martins AJ, Radtke AJ, Hoehn KB, Oguz C, Chen J, Liu C, Tang J, Grubbs G, Stein S, Ramelli S, Kabat J, Behzadpour H, Karkanitsa M, Spathies J, Kalish H, Kardava L, Kirby M, Cheung F, Preite S, Duncker PC, Kitakule MM, Romero N, Preciado D, Gitman L, Koroleva G, Smith G, Shaffer A, McBain IT, McGuire PJ, Pittaluga S, Germain RN, Apps R, Schwartz DM, Sadtler K, Moir S, Chertow DS, Kleinstein SH, Khurana S, Tsang JS, Mudd P, Schwartzberg PL, Manthiram K. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat Immunol. 2023 Jan;24(1):186-199. doi: 10.1038/s41590-022-01367-z. Epub 2022 Dec 19.
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Munsjukdomar
- Stomatogena sjukdomar
- Sjukdomar i nervsystemet
- Genetiska sjukdomar, medfödda
- Luftvägsinfektioner
- Infektioner
- Luftvägssjukdomar
- Andningsstörningar
- Vakna sömnstörningar
- Hudsjukdomar
- Otorhinolaryngologiska sjukdomar
- Apné
- Sömnstörningar, inneboende
- Dyssomni
- Hudsjukdomar, genetiska
- Faryngeala sjukdomar
- Stomatit
- Medfödda, ärftliga och neonatala sjukdomar och abnormiteter
- Hud- och bindvävssjukdomar
- Sömnapnésyndrom
- Sömnapné, obstruktiv
- Ärftliga autoinflammatoriska sjukdomar
- Faryngit
- Halsfluss
- Stomatit, Afthous
Andra studie-ID-nummer
- 10001043
- 001043-I
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Deidentified IPD that underlie results in a publication or associated with genomic data deposited in a data base will be shared.
Tidsram för IPD-delning
Will be shared at the time of publication or data deposition into data base.
Kriterier för IPD Sharing Access
Individual level data in dbGaP is controlled access as investigators must place a request and be approved by dbGaP. Aggregated data will be open access.
IPD-delning som stöder informationstyp
- STUDY_PROTOCOL
- SAV
- ICF
- ANALYTIC_CODE
- CSR
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .